
Peptides
Les peptides sont des chaînes courtes d'acides aminés liées par des liaisons peptidiques, jouant un rôle essentiel en tant que molécules biologiques dans divers processus cellulaires. Ils fonctionnent comme hormones, neurotransmetteurs et molécules de signalisation, et sont largement utilisés dans les applications thérapeutiques et diagnostiques. Les peptides sont également cruciaux dans la recherche pour étudier les interactions protéiques, les activités enzymatiques et les voies de signalisation cellulaire. Chez CymitQuimica, nous proposons une large sélection de peptides de haute qualité pour soutenir vos besoins en recherche et développement en biotechnologie et en pharmacie.
Sous-catégories appartenant à la catégorie "Peptides"
30318 produits trouvés pour "Peptides"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
[Nle253]-HSV-1 UL 26 Open Reading Frame (238-257)
<p>Catalogue peptide; min. 95% purity</p>Formule :C102H152N26O29Masse moléculaire :2,206.51 g/molHistone H1-derived peptide
<p>Catalogue peptide; min. 95% purity</p>Formule :C56H101N17O15Masse moléculaire :1,252.53 g/mol[D-Trp2,7,9]-Substance P
<p>Catalogue peptide; min. 95% purity</p>Formule :C80H109N21O13SMasse moléculaire :1,604.96 g/mol[D-Cys6,Asn7,D-Ala11,Cys14]-Bombesin (6-14)
<p>Catalogue peptide; min. 95% purity</p>Formule :C44H64N14O10S2Masse moléculaire :1,013.22 g/mol[Phe2]-TRH
<p>Catalogue peptide; min. 95% purity</p>Formule :C19H24N4O4Masse moléculaire :372.44 g/molbeta-Casomorphin, human
<p>Catalogue peptide; min. 95% purity</p>Formule :C44H61N7O11Masse moléculaire :864.02 g/molMBP (1-17)
<p>Catalogue peptide; min. 95% purity</p>Formule :C79H135N27O26Masse moléculaire :1,879.12 g/molabII probe
<p>Catalogue peptide; min. 95% purity</p>Formule :C63H101N19O19SMasse moléculaire :1,460.69 g/molCalmodulin-Dependent Protein Kinase II (281-309)
<p>Catalogue peptide; min. 95% purity</p>Formule :C146H254N46O39S3Masse moléculaire :3,374.05 g/molBrain injury Derived Neurotrophic Peptide(3) BINP
<p>Catalogue peptide; min. 95% purity</p>Formule :C62H101N17O19Masse moléculaire :1,388.58 g/molInfluenza HA (529-537)
<p>Catalogue peptide; min. 95% purity</p>Formule :C41H67N9O13Masse moléculaire :894.04 g/mol[Lys8,Asn9] Neurotensin LANT-6 (8-13)
<p>Catalogue peptide; min. 95% purity</p>Formule :C36H58N8O9Masse moléculaire :746.91 g/molH-Ser-Ile-Lys-Val-Ala-Val-OH
CAS :<p>H-Ser-Ile-Lys-Val-Ala-Val-OH is a peptide that is synthesized from the amino acid sequence of the human skin cells. It has been shown to be effective in inhibiting bacterial growth and inducing death in bacteria. This peptide binds to the bacterial cell wall and inhibits its growth. The polymer film can be used for the delivery of H-Ser-Ile-Lys-Val-Ala-Val-OH in the form of lamellar, galacturonic acid, collagen, or lipid nanoparticles. The lamellar phase can be prepared by using water as solvent and lipids as surfactant. The lipid nanoparticle formulation consists of a core material (e.g., cholesterol) surrounded by a lipid bilayer composed of phospholipids or glycolipids with H Ser Ile Lys Val Ala Val OH incorporated into it. This peptide has also been shown to have skin care properties when</p>Formule :C28H53N7O8Degré de pureté :Min. 95%Masse moléculaire :615.76 g/molAutocamtide-3 [KKALHRQETVDAL]
<p>Catalogue peptide; min. 95% purity</p>Formule :C65H113N21O20Masse moléculaire :1,508.75 g/molBax-BH3L63A
<p>Catalogue peptide; min. 95% purity</p>Formule :C74H129N22O27SMasse moléculaire :1,791.05 g/molSomatostatin-14 (3-14)
<p>Catalogue peptide; min. 95% purity</p>Formule :C71H96N16O17S2Masse moléculaire :1,509.78 g/mol[D-Pro10]-Dynorphin A (1-11), porcine
<p>Catalogue peptide; min. 95% purity</p>Formule :C63H103N21O13Masse moléculaire :1,362.66 g/molbeta-Amyloid (11-22)
<p>Catalogue peptide; min. 95% purity</p>Formule :C70H102N18O18Masse moléculaire :1,483.70 g/molα-Bag Cell Peptide (1-7)
<p>Catalogue peptide; min. 95% purity</p>Formule :C44H67N13O9Masse moléculaire :922.11 g/molFmoc-Phe-Wang resin (100-200 mesh)
<p>Please enquire for more information about Fmoc-Phe-Wang resin (100-200 mesh) including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Degré de pureté :Min. 95%Dynorphin (2-17), amide, porcine
<p>Catalogue peptide; min. 95% purity</p>Formule :C90H147N31O20Masse moléculaire :1,983.37 g/molCys-Gly-Lys-Lys-Gly-Amyloid beta-Protein (36-42)
<p>Catalogue peptide; min. 95% purity</p>Formule :C47H85N14O13SMasse moléculaire :1,087.35 g/mol[Lys3, Phe10, Tyr13]-Autocamtide-2-Related Inhibitory Peptide (AIP) Analog
<p>Catalogue peptide; min. 95% purity</p>Formule :C74H121N23O20Masse moléculaire :1,652.93 g/molZ-N-Me-Ser(tBu)-OH·DCHA
CAS :Please enquire for more information about Z-N-Me-Ser(tBu)-OH·DCHA including the price, delivery time and more detailed product information at the technical inquiry form on this pageFormule :C16H23NO5·C12H23NDegré de pureté :Min. 95%Masse moléculaire :490.68 g/mol[Tyr52] PTH (52-84) (human)
<p>Catalogue peptide; min. 95% purity</p>Formule :C158H262N44O56Masse moléculaire :3,674.02 g/mol[D-Arg0,Hyp2,3,D-Phe7]-Bradykinin
<p>Catalogue peptide; min. 95% purity</p>Formule :C60H87N19O14Masse moléculaire :1,298.48 g/mol[Tyr63] PTH (63-84), human
<p>Catalogue peptide; min. 95% purity</p>Formule :C103H172N28O37Masse moléculaire :2,394.68 g/molAllatostatin VII
Catalogue peptide; min. 95% purityFormule :C46H69N13O13SMasse moléculaire :1,044.2 g/molGlucagon-Like Peptide 1, (GLP-1) amide, human
<p>Catalogue peptide; min. 95% purity</p>Formule :C184H273N51O57Masse moléculaire :4,111.53 g/molY-R-G-D-S
<p>Catalogue peptide; min. 95% purity</p>Formule :C24H36N8O10Masse moléculaire :596.60 g/molBiotin-Galanin, human
<p>Catalogue peptide; min. 95% purity</p>Formule :C149H224N44O45SMasse moléculaire :3,383.78 g/molBNP (1-21), Pro (Human)
<p>Catalogue peptide; min. 95% purity</p>Formule :C89H144N28O35Masse moléculaire :2,166.31 g/molDok-4 (130-145)
<p>Catalogue peptide; min. 95% purity</p>Formule :C83H128N22O25SMasse moléculaire :1,866.1 g/molbeta-Amyloid/A4 Protein Precursor (APP) (328-332)
<p>Catalogue peptide; min. 95% purity</p>Formule :C25H47N11O9SMasse moléculaire :677.79 g/molCasein Kinase II Receptor Peptide
<p>Catalogue peptide; min. 95% purity</p>Formule :C52H87N19O24Masse moléculaire :1,362.3 g/molIntermedin (human)
<p>Catalogue peptide; min. 95% purity</p>Formule :C219H351N69O66S3Masse moléculaire :5,102.84 g/mol[D-Ala2,Met5]-beta-Casomorphin (1-5), bovine
<p>Catalogue peptide; min. 95% purity</p>Formule :C31H41N5O7SMasse moléculaire :627.78 g/molH-D-Arg-Arg-Pro-Hyp-Gly-beta-(2-thienyl)-Ala-Ser-D-Phe-b-(2-thienyl)-Ala-Arg-OH
CAS :<p>Enalaprilat is a prodrug that is converted to the active drug enalapril in vivo. It is a potent angiotensin-converting enzyme (ACE) inhibitor that prevents the conversion of angiotensin I to angiotensin II, which leads to vasodilatation and reduced blood pressure. Enalaprilat has been shown to be effective in lowering blood pressure in patients with cardiac insufficiency or hypertension. It also has been shown to decrease the production of endogenous bradykinin, which acts on its receptor B2, leading to vasodilatation and reduced blood pressure. The most common side effect of enalaprilat therapy is cutaneous reactions such as erythema, rash, or pruritus.</p>Formule :C56H83N19O13S2Degré de pureté :Min. 95%Masse moléculaire :1,294.51 g/mol[Tyr4]-MBP (1-11)
<p>Catalogue peptide; min. 95% purity</p>Formule :C55H85N21O18Masse moléculaire :1,328.42 g/molGnT-V (nt38-67)
<p>Catalogue peptide; min. 95% purity</p>Formule :C54H89N13O13SMasse moléculaire :1,159.45 g/molFmoc-Val-Wang resin (100-200 mesh)
<p>Please enquire for more information about Fmoc-Val-Wang resin (100-200 mesh) including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Degré de pureté :Min. 95%Peptide Lv (rat) trifluoroacetate salt
CAS :<p>Please enquire for more information about Peptide Lv (rat) trifluoroacetate salt including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formule :C262H415N73O72S2Degré de pureté :Min. 95%Masse moléculaire :5,803.68 g/molPannexin-1 Fragment (4515)
<p>Catalogue peptide; min. 95% purity</p>Formule :C59H104N22O20Masse moléculaire :1,441.62 g/molH-Glu(EDANS)-Pro-Leu-Phe-Ala-Glu-Arg-Lys(DABCYL)-OH
CAS :<p>Please enquire for more information about H-Glu(EDANS)-Pro-Leu-Phe-Ala-Glu-Arg-Lys(DABCYL)-OH including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formule :C72H97N17O16SDegré de pureté :Min. 95%Masse moléculaire :1,488.71 g/molDelta-Sleep Inducing Peptide trifluoroacetate salt
CAS :<p>Delta-Sleep Inducing Peptide trifluoroacetate salt H-Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu-OH trifluoroacetate salt is a peptide that has been shown to have a hypnotic effect in mice. It was found to increase the time spent on the rotarod and decrease locomotor activity in mice. This drug has also been shown to be hypoglycemic and to modulate transcriptional regulation of fatty acid metabolism. Delta Sleep Inducing Peptide trifluoroacetate salt H-Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly Gly Glu OH trifluoroacetate salt may be useful in treating autoimmune diseases, such as multiple sclerosis, due to its ability to regulate 5HT concentrations.</p>Formule :C35H48N10O15Masse moléculaire :848.81 g/molGIP, porcine
<p>Catalogue peptide; min. 95% purity</p>Formule :C225H342N60O66SMasse moléculaire :4,975.66 g/mol(Hyp 3,b-(2-thienyl)-Ala5,Tyr(Me)8-psi(CH2NH)Arg9)-Bradykinin trifluoroacetate salt
CAS :<p>Bradykinin is a peptide hormone that is produced in the body and has various physiological effects, such as vasodilation, bronchoconstriction, and the release of histamine from mast cells. Bradykinin is also used in pharmacological treatments for malignant brain tumors, congestive heart failure, and epidermal growth factor-responsive dermatoses. Bradykinin can be administered intravenously or subcutaneously to treat these conditions. The drug can also be administered intraperitoneally to treat high blood pressure during pregnancy. Bradykinin is an ester of 3-b-(2-thienyl)-Ala5,Tyr(Me)8-psi(CH2NH)Arg9-OH with trifluoroacetic acid. It is synthesized by linking two molecules together through an ester bond. This drug has many beneficial effects on the human body due to its ability to inhibit enzymes that are involved in the production of prostagland</p>Formule :C49H75N15O12SDegré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :1,098.28 g/mol
